<DOC>
	<DOCNO>NCT00147797</DOCNO>
	<brief_summary>The advent new antiretroviral agent , particular Highly Active Antiretroviral Therapy ( HAART ) , spectacularly reduce HIV-associated morbidity mortality . However , new complication appear HIV-infected patient treat HAART dyslipidemia , insulin resistance , diabetes mellitus , relate cardiovascular complication include acute coronary syndrome , peripheral vascular disease , stroke report . A linear association prove increased intima-media thickness common carotid artery ( CCA-IMT ) , aortic stiffness ( pulse wave velocity [ aPWV ] ) incidence cardiovascular event suggest IMT aPWV could consider early marker atherosclerosis . The progression IMT show predictive cardiovascular event . Case control longitudinal study suggest increase CCA-IMT HIV-infected patient HAART compare non-HIV infected patient different progression . The aim study examine effect pravastatin CCA-IMT aortic stiffness dyslipidemic HIV-infected patient receive HAART use high-resolution echotracking system . Patients pravastatin group consecutively recruit four department infectious disease fulfil follow criterion : ( 1 ) HIV-infected treat HAART &gt; 12 month 2 ) dyslipidemia , define fast serum LDL cholesterol &gt; 160 mg/dL initiation pravastatin , ( 3 ) treat pravastatin &gt; 12 month one coronary risk factor . The patient control group select consecutively department among 1 ) HIV-infected patient treat HAART &gt; 12 month 2 ) fast serum LDL cholesterol &gt; 160 mg/dL 3 ) without lipid-lowering drug one coronary risk factor . Cases control patient match age , gender tobacco consumption . Using data Mercie et al. , inclusion 42 patient pravastatin control group minimum sample size need detection 6.5 % difference CCA-IMT , two-sided test ( = 0.05 , b = 0.20 ) . The protocol study , sponsor French Society Cardiology approve Committee Protection Human Subjects Biomedical Research Pitié-Salpétrière University hospital Paris . Written inform consent participate study obtain patient .</brief_summary>
	<brief_title>Influence Pravastatin Carotid Artery Structure Function HIV-infected Patients Under Antiretroviral Therapy</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<criteria>HIVinfected patient treat HAART &gt; 12 month With dyslipidemia , define LDL cholesterol &gt; 160 mg/dL initiation statin Treated pravastatin &gt; 12 month one coronary risk factor . The patient control group select consecutively department among HIVinfected patient treat HAART &gt; 12 month LDL cholesterol &gt; 160 mg/dL Without lipidlowering drug one coronary risk factor . Cases control patient match age , gender tobacco consumption . Patients history coronary artery disease , peripheral artery disease , endarterectomy , aortic dissection</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Atherosclerosis</keyword>
	<keyword>intima medium thickness</keyword>
	<keyword>aortic stiffness</keyword>
	<keyword>HIV infection</keyword>
	<keyword>Dyslipidemia</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>